AZRX
AzurRx BioPharma Inc
Halal Rating :
Last Price
$0.55
Last updated:
Market Cap
-
7D Change
1.68%
1 Year Change
-84.27%
Company Overview
Exchange
Next Earnings Date
AzurRx BioPharma Inc is a clinical-stage biopharmaceutical company focused on developing non-systemic, targeted recombinant therapies for gastrointestinal diseases. The company's main focus is on developing treatments for exocrine pancreatic insufficiency and other GI diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate AzurRx BioPharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.